RE:RE:Korelin Report Link - 10/21/2016Agreed. People just really don't understand the immense potential here. They have thus far doubled the previous record for post-treatment survival in rats suffering from brain cancer. That would be like an athlete going out tomorrow and posting 59 feet in the long jump. UNHEARD OF!
And the company just keeps check-boxing the operational and regulatory milestones. In my view it will take positive Ph. 1 results before the market really catches on and takes notice, but once that's accomplished I think TLT could very possibly make NASA jealous with their vertical share price propulsion system.
And that's only in NMIBC. They have now also established unprecedented animal-model efficacy in glioblastoma, an entirely new vertical.
vestor111 wrote: The rat model is a world record!
"Nothing prevents us from re-treating..."
No wonder why shortie wants your shares...CHEAP!